Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.
Rising standards of patient care are driving PACS adoption among top-quality medical facilities in Japan, South Korea, and China, making the Asia-Pacific region the third largest PACS market after the U.S. and Europe, according to an industry report from Frost & Sullivan.
The annual average PACS growth rate of 20% in China expected over the next five years is the highest in the world. The growth rate in Japan and South Korea is half that of China.
The surging interest seen in Asia presents new opportunities and challenges for multinational PACS manufacturers. To successfully participate in the region, PACS vendors must adapt their technology to meet specific characteristics demanded by each country.
China, Southeast Asia, and South Korea typically use radiology information and hospital information systems that do not comply with the U.S. HL7 standard. Instead, these countries opt for a variety of local language-based systems that operate on 2-bit characters.
On the other hand, the U.S. patient care model is already popular in areas such as Malaysia, Singapore, Australia, New Zealand, and Hong Kong.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.